Healsun Biopharm
company
About
Healsun Biopharm is a pharmaceutical company.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥250M
- Industries
- Biopharma,Biotechnology,Health Care,Information Technology,Pharmaceutical
- Founded date
- Jan 1, 2015
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Healsun Biopharm is a pharmaceutical company development processes such as molecular construction, stable cell line screening, cell culture process development, protein purification and process development, antibody-coupled drug process development and bioanalytical method development.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥250M
Healsun Biopharm has raised a total of
¥250M
in funding over 2 rounds. Their latest funding was raised on
Aug 19, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 19, 2022 | Series B | ¥250M | 3 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
3
Healsun Biopharm is funded by 3 investors.
Orient Jiafu Asset Management
and Xinghua Dingli
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
HT Capital
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
